Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

Literature DB >> 33530703

Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

Tatjana Josefs^1,2,3, Debapriya Basu^4,2,3, Tomas Vaisar⁵, Britt Arets, Jenny E Kanter⁵, Lesley-Ann Huggins⁴, Yunying Hu⁴, Jianhua Liu¹, Noemie Clouet-Foraison⁵, Jay W Heinecke⁵, Karin E Bornfeldt⁵, Ira J Goldberg⁴, Edward A Fisher¹.

Abstract

[Figure: see text].

Entities: Chemical

Keywords: atherosclerosis; cardiovascular disease; lipoprotein lipase; lipoproteins; macrophages; triglyceride

Mesh：

Substances：

Year: 2021 PMID： 33530703 PMCID： PMC7979499 DOI： 10.1161/CIRCRESAHA.120.317458

Source DB: PubMed Journal: Circ Res ISSN： 0009-7330 Impact factor: 17.367

72 in total

1. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.

Authors: Tomáš Vaisar; Chongren Tang; Ilona Babenko; Patrick Hutchins; Jake Wimberger; Anthony F Suffredini; Jay W Heinecke
Journal: J Lipid Res Date: 2015-05-20 Impact factor: 5.922

2. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

Authors: Masa-aki Kawashiri; Toshinori Higashikata; Mihoko Mizuno; Mutsuko Takata; Shoji Katsuda; Kenji Miwa; Tsuyoshi Nozue; Atsushi Nohara; Akihiro Inazu; Junji Kobayashi; Junji Koizumi; Hiroshi Mabuchi
Journal: J Clin Endocrinol Metab Date: 2005-09-20 Impact factor: 5.958

3. Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

Authors: Kalyani G Bharadwaj; Yaeko Hiyama; Yunying Hu; Lesley Ann Huggins; Rajasekhar Ramakrishnan; Nada A Abumrad; Gerald I Shulman; William S Blaner; Ira J Goldberg
Journal: J Biol Chem Date: 2010-09-18 Impact factor: 5.157

4. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo.

Authors: V R Babaev; S Fazio; L A Gleaves; K J Carter; C F Semenkovich; M F Linton
Journal: J Clin Invest Date: 1999-06 Impact factor: 14.808

Review 5. Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions.

Authors: Eugene Trogan; Edward A Fisher
Journal: Methods Mol Biol Date: 2005

6. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.

Authors: Elda Favari; Miriam Lee; Laura Calabresi; Guido Franceschini; Francesca Zimetti; Franco Bernini; Petri T Kovanen
Journal: J Biol Chem Date: 2003-12-29 Impact factor: 5.157

7. Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression.

Authors: Ayanna Augustus; Hiroaki Yagyu; Guenter Haemmerle; André Bensadoun; Reeba K Vikramadithyan; So-Young Park; Jason K Kim; Rudolf Zechner; Ira J Goldberg
Journal: J Biol Chem Date: 2004-03-17 Impact factor: 5.157

8. Plasminogen promotes cholesterol efflux by the ABCA1 pathway.

Authors: Nathalie Pamir; Patrick M Hutchins; Graziella E Ronsein; Hao Wei; Chongren Tang; Riku Das; Tomas Vaisar; Edward Plow; Volker Schuster; Marlys L Koschinsky; Catherine A Reardon; Richard Weinberg; David A Dichek; Santica Marcovina; Godfrey S Getz; Jay W Heinecke
Journal: JCI Insight Date: 2017-08-03

9. The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism.

Authors: Xian-Cheng Jiang; Weijun Jin; Mahmood M Hussain
Journal: Nutr Metab (Lond) Date: 2012-08-16 Impact factor: 4.169

10. Effects of extended-release niacin with laropiprant in high-risk patients.

Authors: Martin J Landray; Richard Haynes; Jemma C Hopewell; Sarah Parish; Theingi Aung; Joseph Tomson; Karl Wallendszus; Martin Craig; Lixin Jiang; Rory Collins; Jane Armitage
Journal: N Engl J Med Date: 2014-07-17 Impact factor: 91.245

10 in total

1. CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Authors: Masami Shimizu-Albergine; Debapriya Basu; Jenny E Kanter; Farah Kramer; Vishal Kothari; Shelley Barnhart; Carissa Thornock; Adam E Mullick; Noemie Clouet-Foraison; Tomas Vaisar; Jay W Heinecke; Robert A Hegele; Ira J Goldberg; Karin E Bornfeldt
Journal: J Clin Invest Date: 2021-11-15 Impact factor: 14.808

Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice.

1. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.

2. Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis.

3. Chylomicron- and VLDL-derived lipids enter the heart through different pathways: in vivo evidence for receptor- and non-receptor-mediated fatty acid uptake.

4. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo.

Review 5. Laser capture microdissection for analysis of macrophage gene expression from atherosclerotic lesions.

6. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.

7. Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression.

8. Plasminogen promotes cholesterol efflux by the ABCA1 pathway.

9. The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism.

10. Effects of extended-release niacin with laropiprant in high-risk patients.

1. CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Review 2. The Remnant Lipoprotein Hypothesis of Diabetes-Associated Cardiovascular Disease.

Review 3. The role of lipid metabolism in shaping the expansion and the function of regulatory T cells.

Review 4. Addressing dyslipidemic risk beyond LDL-cholesterol.

5. Reducing Endogenous Labile Zn May Help to Reduce Smooth Muscle Cell Injury around Vascular Stents.

Review 6. Trafficking of Mononuclear Phagocytes in Healthy Arteries and Atherosclerosis.

Review 7. Macrophages in Atheromatous Plaque Developmental Stages.

Review 8. Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms.

Review 9. Cardiovascular disease in diabetes, beyond glucose.

10. Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis.